Achelios Therapeutics

Achelios Therapeutics is a pharmaceutical development company advancing new product concepts through preclinical and early clinical POC.

Achelios Therapeutics is a pharmaceutical development company that focuses on advancing new product concepts through the 505(b)(2) process to early clinical proof of principle followed by asset (project) sale. Achelios has adopted a semi-virtual model to control costs and advance projects by utilizing its experienced team and on-call external pharmaceutical experts and partners. This allows the company’s management to precisely tailor project needs with the right level of expertise and/or key opinion leaders with influence at the FDA, academic medicine centers, and at the level of the payer (insurance company/government).